EuroPCR 2024: Late-Breaking Science Video Collection

Published: 20 May 2024

  • Views:

    Views Icon 1136

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Our regular review series View From the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) dives deep into the late-breaking trials of EuroPCR 2023, spotlighting the impactful data.

For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research. 

Hear commentary on the practice-changing trials of EuroPCR 2024 from selected faculty in our Highlights Reviews.

More from this programme

Part 1

Expert Interviews

6 sessions
Self-Expandable Vs Balloon-Expandable Valves & General Vs Local Anesthesia in TAVI: SOLVE-TAVI Watch now
Influence of Pathophysiological Patterns of CAD on PCI Watch now
Ancillary SMART Trial Analyses Watch now
Impact of Diabetes Severity After Abluminus DES+ Stent: ABILITY Watch now
TAVR Vs SAVR in Younger Low-Risk Patients with Severe Aortic Valve Stenosis: NOTION-2 Watch now
1M DAPT Followed by 5M Ticagrelor Monotherapy in ACS with DCB: CAGEFREE II Watch now

Part 2

View from the Thoraxcenter

2 sessions
View from the Thoraxcenter: What's Hot at EuroPCR 24? Watch now
View from the Thoraxcenter: EuroPCR 24 Wrap Up - Part 1 Watch now

Part 3

Highlights Reviews

2 sessions
5 Trials That Will Change My Practice With Dr Mirvat Alasnag Watch now
4 Trials That Will Change My Practice with Dr Bernardo Cortese Watch now

About the episode

What's hot at EuroPCR 2024?

Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.

What is the potential impact of the new data on practice? What details should we look out for? What is the context of the EuroPCR trials?

Trials covered included:
00:46 - CAREER: Diagnostic performance of fully automatic computational FFR
02:03 - Angiography-based Radial Wall Strain in Predicting Non-Culprit Vessel Failure
04:05 - DOCTORS-LM: Does OCT Optimise Results of Stenting on the Left Main Stem
07:41 - TCW: Percutaneus versus surgical treatment for patients with aortic stenosis and coronary disease
09:35 - SOLVE-TAVI: mpact of valve type and anaesthesia strategy for TAVI 
12:27 - NOTION-2: First TAVI vs SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis
14:41 - LANDMARK: Early outcomes of a randomised non-inferiority trial comparing TAVI devices
16:36 - AltaValve: Early feasibility study
17:53 - LuxValvePlus: Transcatheter tricuspid valve implantation using the LuxValvePlus system: Compassionate use outcomes
19:12 - CALIPSO: OCT vs angiography for guidance of calcified lesions PCI
21:44 - ROTA-ISR: Debulking with rotational atherectomy versus balloon angioplasty in patients with in-stent restenosis
23:57 - ROLLERCOASTR: Balloon angioplasty versus shockwave intravascular lithotripsy
25:20 - Balloon Angioplasty Vs Shockwave Intravascular Lithotripsy
25:29 - OCT Vs IVUS: Primary outcome of randomised controlled trial of the safety and effectiveness for OCT or IVUS-guide

Faculty Biographies

Joost Daemen

Joost Daemen

Interventional Cardiologist

Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. He is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

View full profile
Nicolas M Van Mieghem

Nicolas M Van Mieghem

Medical Director

Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

His current research focuses on cerebral embolic protection during TAVI and the search for improved…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.